The Billion-Dollar Molecule

Barry Werth


Engels | 01-03-1995 | 464 pagina's

9780671510572

Paperback / softback


  Bekijk inkijkexemplaar

€ 22,95

 Voorraad in de winkel
   Bestelbaar

   Ruilen mogelijk binnen de 14 dagen (niet op specifieke bestellingen)

   Gratis leveren aan huis in Sint-Niklaas




Korte beschrijving/Annotatie

Join journalist Barry Werth as he unveils the intense drama at Vertex, a start-up pharma company, focused on pioneering drug research for immunosuppressants and AIDS.

Tekst achterflap

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research.

Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.

You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.

Beschrijving

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research.

Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.

You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.

Details

EAN :9780671510572
Auteur: 
Uitgever :Simon & Schuster Nederland B.V.
Publicatie datum :  01-03-1995
Uitvoering :Paperback / softback
Taal/Talen : Engels
Hoogte :216 mm
Breedte :140 mm
Dikte :32 mm
Gewicht :377 gr
Status : Bestelbaar
Aantal pagina's :464
Reeks :  Touchstone Book